Global Plasma Fractionation Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

Global Plasma Fractionation Market Overview

"The Plasma Fractionation Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031."

Request Covid - 19 Impact

Blood plasma is the liquid component of whole blood, that makes up approximately 55% of the total blood volume. It comprises mainly of water, with some minerals, salts, etc. A variety of proteins such as albumin, immunoglobulins, and fibrinogen can be found in plasma. Plasma fractionation is the process of separating various components of blood plasma. Plasma fractionation is primarily used in treatment of protein deficiency in individuals and also as a packaging material for industrial applications.

Increasing use of immunoglobulins in various therapeutic applications and high prevalence rate coupled with increasing incidence of respiratory diseases and alpha-1 antitrypsin deficiency (ATTD) are major factors driving growth of the global plasma fractionation market. In addition, increasing geriatric population across the globe and high prevalence of immune disorders among them are other factors anticipated to fuel growth of the global plasma fractionation market over the forecast period.

However, high costs associated with plasma fractionation is a key factor restraining the growth of the global plasma fractionation market. Additionally, limited reimbursement policies and the development of alternatives for plasma fractionation are other factors expected to hamper the growth of the global market over the forecast period.

Currently, North America dominates the global plasma fractionation market in revenue terms owing to the increasing use of immunoglobulins in neurological diseases and availability of appropriate healthcare infrastructure in countries in the region.

The market in Asia Pacific accounted for the second-highest revenue share in the global plasma fractionation market, due to high expenditure for development of proper healthcare infrastructure by governments of countries, and high prevalence of hemophilia in emerging economies such as China, India, and Japan.

The markets in Latin America, Europe, and Middle East & Africa are all anticipated to witness moderate growth over the forecast period. Moreover, the market in Asia Pacific is projected to witness fastest growth over the forecast period.

Global plasma fractionation market segmentation:

By product type:

• Albumin
• Immunoglobulins
• Coagulation factor concentrates
• Others

By application:

• Neurology
• Hematology
• Immunology
• Critical Care
• Others

By end user:

• Hospitals and Clinics
• Clinical Research Laboratories
• Academic Institutes

By region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa